These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 26809022)
1. Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates. Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y Helicobacter; 2016 Oct; 21(5):382-8. PubMed ID: 26809022 [TBL] [Abstract][Full Text] [Related]
2. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy. Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area. Georgopoulos SD; Xirouchakis E; Martinez-Gonzalez B; Sgouras DN; Spiliadi C; Mentis AF; Laoudi F Helicobacter; 2013 Dec; 18(6):459-67. PubMed ID: 23714140 [TBL] [Abstract][Full Text] [Related]
4. Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial. Zhou L; Zhang J; Song Z; He L; Li Y; Qian J; Bai P; Xue Y; Wang Y; Lin S Helicobacter; 2016 Apr; 21(2):91-9. PubMed ID: 26104022 [TBL] [Abstract][Full Text] [Related]
5. Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate. Wu JY; Hsu PI; Wu DC; Graham DY; Wang WM Helicobacter; 2014 Jun; 19(3):207-13. PubMed ID: 24612093 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of moxifloxacin-based sequential and hybrid therapy for first-line Helicobacter pylori eradication. Hwang JJ; Lee DH; Yoon H; Shin CM; Park YS; Kim N World J Gastroenterol; 2015 Sep; 21(35):10234-41. PubMed ID: 26401089 [TBL] [Abstract][Full Text] [Related]
7. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111 [TBL] [Abstract][Full Text] [Related]
8. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains. Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326 [TBL] [Abstract][Full Text] [Related]
9. Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial. Chen KY; Lin TJ; Lin CL; Lee HC; Wang CK; Wu DC World J Gastroenterol; 2015 Sep; 21(36):10435-42. PubMed ID: 26420970 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study. Kwon YH; Kim N; Lee JY; Choi YJ; Yoon K; Nam RH; Suh JH; Lee JW; Lee DH Scand J Gastroenterol; 2016 Mar; 51(3):270-6. PubMed ID: 26452405 [TBL] [Abstract][Full Text] [Related]
11. Hybrid Therapy Regimen for Helicobacter Pylori Eradication. Song ZQ; Liu J; Zhou LY Chin Med J (Engl); 2016 Apr; 129(8):992-9. PubMed ID: 27064046 [TBL] [Abstract][Full Text] [Related]
12. Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice. Fiorini G; Zullo A; Saracino IM; Gatta L; Pavoni M; Vaira D Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):621-625. PubMed ID: 29481383 [TBL] [Abstract][Full Text] [Related]
13. Randomised clinical trial comparing concomitant and hybrid therapy for eradication of Helicobacter pylori infection. Mestrovic A; Perkovic N; Bozic J; Pavicic Ivelja M; Vukovic J; Kardum G; Puljiz Z; Tonkic A PLoS One; 2020; 15(12):e0244500. PubMed ID: 33378403 [TBL] [Abstract][Full Text] [Related]
14. Esomeprazole, minocycline, metronidazole and bismuth as first-line and second-line regimens for Helicobacter pylori eradication. Song ZQ; Zhou LY J Dig Dis; 2016 Apr; 17(4):260-7. PubMed ID: 26946480 [TBL] [Abstract][Full Text] [Related]
15. Rabeprazole, Minocycline, Amoxicillin, and Bismuth as First-Line and Second-Line Regimens for Helicobacter pylori Eradication. Song Z; Suo B; Zhang L; Zhou L Helicobacter; 2016 Dec; 21(6):462-470. PubMed ID: 27060292 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion. Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010 [TBL] [Abstract][Full Text] [Related]
17. Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions. Martos M; Bujanda L; Salicio Y; Sarasqueta C; Ibarra B; Mendarte U; Fernández-Reyes M; Cosme A Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1380-4. PubMed ID: 25229983 [TBL] [Abstract][Full Text] [Related]
18. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia. Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790 [TBL] [Abstract][Full Text] [Related]
19. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial. Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272 [TBL] [Abstract][Full Text] [Related]
20. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study. Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]